1. Which of the following is true regarding the local reaction known as “COVID arm” to the first dose of Moderna COVID-19 vaccine?
A. May occur several days after injection
B. Typically lasts for several hours before ceasing
C. Requires omitting second dose
D. Reaction is consistent with allergic reaction
E. Unsure
2. Which of the following is true regarding vaccination of pregnant patients with mRNA vaccines?
A. Data are insufficient to explicitly recommend either of the available mRNA COVID-19 vaccines
B. If choosing an mRNA vaccine, the Moderna product would be preferred over Pfizer/BioNTech product
C. A pregnant patient must discuss COVID-19 vaccination with their healthcare provider prior to vaccination
D. Initial animal studies suggest potential damage to the mother but not the fetus
E. Unsure
3. How long should patients with a previous history of anaphylaxis to other vaccines or injectable products be monitored after vaccination with mRNA-1273 or BNT126b2?
A. 15 minutes
B. 30 minutes
C. 45 minutes
D. 60 minutes
E. Unsure
4. Which of the following is a primary strategy for increasing vaccine confidence?
A. Publishing detailed records of manufacturing processes for COVID-19 vaccines
B. Evaluating adverse reactions to COVID-19 vaccines via social media outlets
C. Empowering health professionals through educational efforts and training
D. Focusing education on vaccine confidence in metropolitan areas rather than rural communities
E. Unsure
5. Which of the following vaccine candidates in development contains harvested viral proteins that are formulated into nanoparticles?
A. BNT162b2
B. mRNA-1273
C. NVX-CoV2373
D. Ad26.COV2.S
E. Unsure
6. Which of the following is true regarding the Janssen C0OVID-19 vaccine candidate (Ad26.COV2.S)?
A. It is given as a 2-dose regimen.
B. It may be stored up for at least 3 months refrigerated.
C. Its efficacy in currently reported trials is equivalent to the mRNA vaccines.
D. A large number of subjects included in their reported studies were in the pediatric age group.
E. Unsure
7. Which of the following is true regarding SARS-CoV-2 variants?
A. Vaccines have no effect on the 3 most commonly circulating variants.
B. Future mRNA vaccines could be adjusted to account for several variants.
C. The Brazilian variant (P.1) has been associated with significant increased transmissibility.
D. As of February 2021, none of these variants had entered the United States.
E. Unsure
Evaluation Questions
8. To what extent did the program meet objective #1?
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
9. To what extent did the program meet objective #2?
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
10. Rate the effectiveness of how well the program related to your educational needs:
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
11. Rate how well the active learning strategies (questions, cases, discussions) were appropriate and effective learning tools:
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
12. Rate the quality of the faculty:
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
13. Rate the effectiveness and the overall usefulness of the material presented:
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
14. Rate the appropriateness of the examination for this activity:
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
15. Rate the effectiveness of how well the activity related to your practice needs:
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
16. Rate the effectiveness of how well the activity will help you improve patient care:
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
17. Will the information presented cause you to change your practice?
A. Yes
B. No
18. Are you committed to making these changes?
A. Yes
B. No
19. As a result of this activity, did you learn something new?
A. Yes
B. No
20. What is your practice setting or area of practice?
A. Community Pharmacy/Independent
B. Community Pharmacy/Chain
C. Hospital/Health Systems
D. Administrative/Pharmacy Director
E. Critical Care Pharmacy
F. Long-term Care
G. Managed Care/PBM
H. Oncology
I. Specialty Pharmacy
J. Industry/Manufacturing
21. How many years have you been in practice?
A. <5
B. 5 – 10
C. 11 – 20
D. >20